Your browser doesn't support javascript.
loading
Prevalence, awareness, treatment, and control of hypertension based on ACC/AHA versus JNC7 guidelines in the PERSIAN cohort study.
Sepanlou, Sadaf; Najafi, Farid; Poustchi, Hossein; Parsaeian, Mahboubeh; Ahmadi, Ali; Somi, Mohammadhossein; Moradpour, Farhad; Alizadeh-Navaei, Reza; Gohari, Ali; Zamani, Bijan; Esmaeilinadimi, Ali; Rezaianzadeh, Abbas; Mansour-Ghanaei, Fariborz; Bahramali, Ehsan; Ansari-Moghaddam, Alireza; Hamzeh, Behrooz; Zanganeh Yousefabadi, Elham; Zare Sakhvidi, Mohammad Javad; Mohebbi, Iraj; Fattahi, Mohammad Reza; Nejatizadeh, Azim; Marioryad, Hossein; Motamed-Gorji, Nazgol; Roozafzai, Farzin; Eghtesad, Sareh; Mohammadi, Zahra; Shayanrad, Amaneh; Sharafkhah, Maryam; Etemadi, Arash; Kamangar, Farin; Juraschek, Stephen P; Malekzadeh, Reza.
Affiliation
  • Sepanlou S; Digestive Disease Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Najafi F; Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Poustchi H; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Parsaeian M; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadi A; Department of Epidemiology and Biostatistics, Modeling in Health Research Center, School of Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
  • Somi M; Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Moradpour F; Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Alizadeh-Navaei R; Gastrointestinal Cancer Research Center, Non-Communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
  • Gohari A; Non-Communicable Diseases Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Zamani B; Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran.
  • Esmaeilinadimi A; Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.
  • Rezaianzadeh A; Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Mansour-Ghanaei F; Gastrointestinal and Liver Diseases Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  • Bahramali E; Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
  • Ansari-Moghaddam A; Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
  • Hamzeh B; Research Center for Environmental Determinants of Health, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
  • Zanganeh Yousefabadi E; Department of Internal Medicine, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
  • Zare Sakhvidi MJ; Occupational Health Research Centre, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
  • Mohebbi I; Social Determinants of Health Research Center, Clinical Research Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Fattahi MR; Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Nejatizadeh A; Molecular Medicine Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.
  • Marioryad H; Yasuj University of Medical Sciences, Yasuj, Iran.
  • Motamed-Gorji N; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Roozafzai F; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Eghtesad S; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Mohammadi Z; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Shayanrad A; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Sharafkhah M; Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Etemadi A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Kamangar F; Department of Biology, School of Computer, Mathematical, and Natural Sciences, Morgan State University, Baltimore, MD, USA.
  • Juraschek SP; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
  • Malekzadeh R; Digestive Oncology Research Center, Digestive Diseases Research Institute, Shariati Hospital, Tehran University of Medical Sciences, North Kargar Ave., Tehran, 14117-13135, Iran. malek@tums.ac.ir.
Sci Rep ; 12(1): 4057, 2022 03 08.
Article in En | MEDLINE | ID: mdl-35260709
ABSTRACT
In this cross-sectional population-based study, we used the baseline data of the Prospective Epidemiologic Research Studies in IrAN cohort study collected in Iran from 2014 to 2020. The main outcomes were the prevalence of hypertension and proportion of awareness, treatment, and control based on the 2017 ACC/AHA guideline compared to the seventh report of the Joint National Committee (JNC7). Of the total of 163,770 participants, aged 35-70 years, 55.2% were female. The sex-age standardized prevalence of hypertension was 22.3% (95% CI 20.6, 24.1) based on the JNC7 guideline and 36.5% (31.1, 41.8) based on the ACC/AHA guideline. A total of 24,312 participants [14.1% (10.1, 18.1)] were newly diagnosed based on the ACC/AHA guideline. Compared to adults diagnosed with hypertension based on the JNC7 guideline, the newly diagnosed participants were mainly young literate males who had low levels of risk factors and were free from conventional comorbidities of hypertension. About 30.7% (25.9, 35.4) of them (4.3% of the entire population) were eligible for pharmacologic intervention based on the ACC/AHA guideline. Implementation of the new guideline may impose additional burden on health systems. However, early detection and management of elevated blood pressure may reduce the ultimate burden of hypertension in Iran.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Irán

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypertension Type of study: Diagnostic_studies / Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Male Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Irán